Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan, kokada@jichi.ac.jp.
Kenta
K
Okada
Kazuhiko
K
Kotani
Hiroaki
H
Yagyu
Akihiko
A
Ando
Jun-Ichi
J
Osuga
Shun
S
Ishibashi
D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000069450:Liraglutide; D008297:Male; D008875:Middle Aged; D020098:Natriuretic Peptide, C-Type / Q000097:blood*; D018384:Oxidative Stress / Q000187:drug effects*
D007004:Hypoglycemic Agents; D020098:Natriuretic Peptide, C-Type; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1